InvestorsHub Logo
Followers 32
Posts 4334
Boards Moderated 0
Alias Born 07/25/2007

Re: jakedogman1 post# 326121

Friday, 04/13/2018 12:50:14 PM

Friday, April 13, 2018 12:50:14 PM

Post# of 346718

My source says the tech is in good hands. Oncologie is a private firm and my guess is that they could care less about a website and telegraphing to the world what they plan on doing. Do you think they give a rat's arse about cdmo retail shareholders? We're not on their make happy list. Would I have preferred BP paid a bunch more on the front end? Yes. But a small firm focused on a few shots on goal versus a BP with hundreds of shots on goal?



The exact opposite is true. I can't believe I have to say this. You want a big company with a lot of financial resources, long expertise on developing oncology drugs and determining the best and most rapid pathway through clinical trials and who also through experience, knows the FDA submission/approval process like the back of their hand. Bavi has a poor MOA and was a prayer but for years and years was being touted by unscrupulous management as the Holy Grail. The price PPHM/CDMO got for their IP and who they sold it to should make that crystal clear.

Building CDMO is a far better way for old PPHM investors to get at least some of their money back. If the new management doesn't have several new clients which significantly increase revenues, say in about a year, then you should start worrying.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News